These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


463 related items for PubMed ID: 25728315

  • 1. Pandemic influenza A vaccination and incidence of Guillain-Barré syndrome in Korea.
    Kim C, Rhie S, Suh M, Kang DR, Choi YJ, Bae GR, Choi YC, Jun BY, Lee JS.
    Vaccine; 2015 Apr 08; 33(15):1815-23. PubMed ID: 25728315
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N, H1N1 GBS Meta-Analysis Working Group.
    Lancet; 2013 Apr 27; 381(9876):1461-8. PubMed ID: 23498095
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
    Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Gutierrez-Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Gimenez-Sanchez F, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H, Global H1N1 GBS Consortium.
    Vaccine; 2013 Sep 13; 31(40):4448-58. PubMed ID: 23770307
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.
    De Wals P, Deceuninck G, Toth E, Boulianne N, Brunet D, Boucher RM, Landry M, De Serres G.
    JAMA; 2012 Jul 11; 308(2):175-81. PubMed ID: 22782419
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans.
    Wise ME, Viray M, Sejvar JJ, Lewis P, Baughman AL, Connor W, Danila R, Giambrone GP, Hale C, Hogan BC, Meek JI, Murphree R, Oh JY, Reingold A, Tellman N, Conner SM, Singleton JA, Lu PJ, DeStefano F, Fridkin SK, Vellozzi C, Morgan OW.
    Am J Epidemiol; 2012 Jun 01; 175(11):1110-9. PubMed ID: 22582209
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination.
    Galeotti F, Massari M, D'Alessandro R, Beghi E, Chiò A, Logroscino G, Filippini G, Benedetti MD, Pugliatti M, Santuccio C, Raschetti R, ITANG study group.
    Eur J Epidemiol; 2013 May 01; 28(5):433-44. PubMed ID: 23543123
    [Abstract] [Full Text] [Related]

  • 14. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe.
    Romio S, Weibel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanström H, Mølgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, Arnheim-Dahlström L, Sparen P, Mosseveld M, Schuemie M, van der Maas N, Jacobs BC, Leino T, Kilpi T, Storsaeter J, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC.
    PLoS One; 2014 May 01; 9(1):e82222. PubMed ID: 24404128
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean.
    Ropero-Álvarez AM, Whittembury A, Bravo-Alcántara P, Kurtis HJ, Danovaro-Holliday MC, Velandia-González M.
    Vaccine; 2015 Jan 01; 33(1):187-92. PubMed ID: 25444798
    [Abstract] [Full Text] [Related]

  • 17. Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic.
    Vellozzi C, Iqbal S, Stewart B, Tokars J, DeStefano F.
    Am J Public Health; 2014 Apr 01; 104(4):696-701. PubMed ID: 24524517
    [Abstract] [Full Text] [Related]

  • 18. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.
    Grimaldi-Bensouda L, Alpérovitch A, Besson G, Vial C, Cuisset JM, Papeix C, Lyon-Caen O, Benichou J, Rossignol M, Lucien Abenhaim for the GBS-PGRx Study Group.
    Am J Epidemiol; 2011 Aug 01; 174(3):326-35. PubMed ID: 21652600
    [Abstract] [Full Text] [Related]

  • 19. Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage.
    Iqbal S, Li R, Gargiullo P, Vellozzi C.
    Vaccine; 2015 Apr 21; 33(17):2045-9. PubMed ID: 25749247
    [Abstract] [Full Text] [Related]

  • 20. Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series.
    Andrews N, Stowe J, Al-Shahi Salman R, Miller E.
    Vaccine; 2011 Oct 19; 29(45):7878-82. PubMed ID: 21875631
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.